Minireviews Open Access
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Apr 16, 2025; 13(11): 98013
Published online Apr 16, 2025. doi: 10.12998/wjcc.v13.i11.98013
Utilizing complementary therapy to enhance quality of life and reduce stress and fatigue in pediatric cancer patients
Luis Carlos Lopes-Júnior, Department of Nursing, Federal University of Espírito Santo, Vitoria 29043-900, Espirito Santo, Brazil
Regina Aparecida Garcia de Lima, Department of Maternal-Infant and Public Health Nursing, University of São Paulo at Ribeirão Preto College of Nursing, Ribeirão Preto 14040-902, Sao Paulo, Brazil
ORCID number: Luis Carlos Lopes-Júnior (0000-0002-2424-6510); Regina Aparecida Garcia de Lima (0000-0002-0611-5621).
Co-first authors: Luis Carlos Lopes-Júnior and Regina Aparecida Garcia de Lima.
Author contributions: Lopes-Júnior LC contributed to resources, supervision, project administration, and funding acquisition; Lopes-Júnior LC and de Lima RAG contributed to conceptualization, methodology, validation, formal analysis and investigation, and wrote the original draft, they contributed equally as co-first authors; and all authors read and agreed to the published version of the manuscript.
Supported by the Coordination of Improvement of Higher Education Personnel (CAPES) and National Council for Scientific and Technological Development (CNPq), No. 311427/2023-5.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Luis Carlos Lopes-Júnior, PhD, Professor, Department of Nursing, Federal University of Espírito Santo, 1468 Avenue Marechal Campos, Vitoria 29043-900, Espirito Santo, Brazil. lopesjr.lc@gmail.com
Received: June 15, 2024
Revised: November 5, 2024
Accepted: December 5, 2024
Published online: April 16, 2025
Processing time: 194 Days and 2.4 Hours

Abstract

The international scientific literature presents still incipient results regarding the management of cancer symptom clusters by oncology nursing, especially in pediatric oncology. This is a promising field of investigation for clinical nurses and researchers, and when it is subsidized by medium-range theories, they corroborate the diagnoses and interventions of nursing in oncology, enhancing the science of nursing care. This minireview article aims to discuss the utilizing the hospital clowns as a complementary therapy, to enhance quality of life and reduce stress and fatigue in pediatric cancer patients. Overall, the evidence presented so far pointed out that complementary therapy might help improve the quality of life of pediatric cancer patients, and that complementary therapy usage should be part of a health comprehensive care model, delivering therapeutic approaches that might enhance the mind-body during a pediatric cancer patients’ life span. The results of scientific investigations by nurses, particularly those linked to the basic sciences, play a critical role in advancing personalized care in pediatric integrative oncology.

Key Words: Cancer symptom clusters; Pediatrics; Pediatric cancer patients; Pediatric integrative oncology; Complementary therapies; Oncology nursing; Hospital clowns; Cancer-related fatigue; Psychological stress; Biomarkers

Core Tip: The international scientific literature presents still incipient results regarding the management of cancer symptom clusters in pediatric oncology. This is a promising field of investigation for clinical nurses and researcher. The evidence presented so far pointed out that complementary therapies might help improve pediatric cancer patient’s quality of life, and that complementary therapies usage should be part of a health comprehensive care model, delivering therapeutic approaches that might enhance the mind-body during a pediatric cancer patients’ life span. The results of scientific investigations carried out by nurses linked to the basic sciences, are the hallmarks of personalized care in pediatric integrative oncology.



INTRODUCTION

More than 15000 new cases of cancer are diagnosed in children and adolescents annually, resulting in 1960 deaths according to the Global Burden of Disease study 2017[1]. For pediatric patients aged 1 to 19 years in the United States, cancer is the leading cause of death by disease. Remarkably, advances in cancer treatment over the past four decades have improved the 5-year survival rate from 10% to approximately 90% in children. However, childhood cancer incidence rates have continuously risen[1,2]. Compared with the adult cancer population, pediatric patients tend to experience higher levels of cancer symptom clusters (CSC)[3,4]. Many of them may live with these symptoms for years after completion of treatment[4]. Parents and caregivers also shoulder a substantial emotional and physical burden due to CSC[5]. Hence, palliating physical and emotional symptoms and providing support to pediatric patients throughout their procedures and treatments, is crucial in cancer care[3,4].

Complementary therapy (CT) can be described as a health care set of techniques aimed at integrating physical, mental, and spiritual dimensions. The National Center for Complementary and Alternative Medicine-National Institutes of Health mainly categorizes them as biologically based therapies, mind-body interventions, manipulative, and body-based methods[5]. The National Center for Complementary and Alternative Medicine classification system was used to discuss the evidence from studies utilizing CT for CSC management in pediatric oncology in this study. The science of CT has significantly grown in the past 60 years with breakthroughs in molecular-level research which help increase the understanding of biological pathways underlying CT use[6].

This minireview aims to discuss the utilizing the hospital clowns (HC) as a CT to enhance quality of life (QoL) and reduce stress and fatigue in pediatric cancer patients. This paper presents the significant contributions made to the field of pediatric integrative oncology (PIO) through the use of CT. In addition, the present study is aligned with objective 3 of the sustainable development goals, which aims to ensure a healthy life and promote well-being for all, at all ages, demonstrating the societal relevance of this work and its potential to address pressing global issues.

TRANSLATIONAL RESEARCH AND CSC IN PEDIATRIC ONCOLOGY

Translational research (TR) refers to the bridge between the new knowledge from the basic sciences and clinical practice. TR has bidirectional phases know as ‘3 Bs’ - bench, bedside, and back again[7]. Biomarkers can be used to characterize both cancer risk and treatment efficacy[8,9]. Immunological biomarkers have been recognized as important in the study of CSC, mainly cytokines[10]. Despite the variety of biomarkers used in early detection, diagnosis, and cancer management the use of biomarkers to assess CSC in pediatric patients remains elusive[3,4]. One of the greatest challenges in oncology nursing is to establish the link between the basic science and application in clinical practice[7].

In clinical practice cancer symptoms rarely occur separately. A cluster is defined as a set of symptoms that are related to each other and that can be predictable[11]. Symptoms group together creating a synergistic effect, which can predict the development of future symptoms. The progression of cancer and treatment can lead to the development of several CSC, e.g., cancer-related fatigue (CRF), pain, sleep disorders, anxiety, depression, etc. Nurses in pediatric oncology must be sensitive to CSC, which may be linked to age, socio-cultural-spiritual aspects, diagnosis and treatment[11]. Overall, these CSC reduce the individual’s functional state and decrease QoL[10,11].

One study compared the levels of interleukin-12 (IL-12) p70 and IL-10 in 59 children with soft tissue sarcoma age range 2-15 years at different stages of treatment, showed that children in remission had decreased IL-10 and increased IL-12 production (P < 0.01)[12]. A recent pilot study which examined the biomarkers associated with stress and CRF in pediatric osteosarcoma patients receiving chemotherapy and under interaction with HC showed reduced cortisol levels over time and also a similar pattern of levels in tumor necrosis factor α for all patients. Also, patients with metastatic osteosarcoma showed a linear trend for reduced levels of matrix metalloproteinase-9 after the HC[13]. Indeed, there is great potential for advancing nursing through research that evaluates the psycho-neuro-immuno-endocrine pathways in the genesis of CSC. Once the association, sensitivity, and specificity of biomarkers has been identified, they can be used in response to accurately determine their effectiveness[12].

Although the growing body of evidence indicates the usefulness of CT in pediatric settings, most studies focus primarily on the adult cancer patient[5]. PIO provides a relationship-centered, evidence-informed personalized approach to the whole child and family system utilizing mind and body practices, natural products and/or lifestyle modifications alongside conventional oncology care[14]. PIO is offered throughout the illness trajectory to optimize health and wellness, enhance healing, minimize suffering, improve QoL and empower children and families to become active participants before, during, and beyond cancer treatment[14]. PIO is still an evolving field requiring further study and efforts should be made with patients, families, and caregivers to participate in these investigations[14]. Pediatric cancer patients may benefit from nonpharmacological interventions including CT to decrease use of medications rendering unwanted side effects[15,16].

COMPLEMENTARY THERAPIES IN PEDIATRIC CANCER PATIENTS

The CT usage for CSC management in pediatric patients range from 31%-84%[17-19]. In PIO, CT are used to help relieve several CSC and side effects, e.g., pain, nausea/vomiting, CRF, sleep disturbance, stress, anxiety, depression, constipation, and diarrhea[20]. Some CT have been well-studied and have significant research to support their use, e.g., relaxation, guided imagery, biofeedback, yoga, and other mind-body therapies (Table 1)[13,21-38].

Table 1 Summary of evidence about use of complimentary therapies in pediatric oncology.
Type of complementary therapy
Patient-reported outcomes
Main findings
Ref.
Manipulative and body-based methods
Therapeutic massageMood and blood cellsDecrease depressed mood as well as to increase white blood cell and neutrophil counts in pediatric cancer patients (P < 0.05)[21,22]
AcupunctureNausea and vomitingReduce chemotherapy-induced nausea and vomiting in children with cancer (P < 0.05)[23]
Mind-body interventions
Music, art, and play therapyAnxiety, pain, psychological stress, and CRFDance therapy may help reduce the symptoms pediatric patients experience during hospitalization, such as anxiety, pain, and fatigue. Total levels of psychological stress and CRF improved after the hospital clown intervention compared with baseline (P = 0.003) and (P = 0.04), respectively. A significant decrease in salivary cortisol after clown intervention was observed (P < 0.05)[13,24-28]
Animal-assisted therapy program (pet-therapy)Stress, pain, mood, anxiety, irritation, depression, quality of life, heart rate, and blood pressurePain, adjustment difficulties, mood changes and symptom management can be improved in inpatient pediatric cancer patients receiving animal-assisted therapy, thus improving overall quality of life. Decrease in pain (P = 0.046), irritation (P = 0.041), and stress (P = 0.005)[29,30]
YogaPain and anxietyAdolescents and parents had a significant decrease in anxiety post yoga intervention (P < 0.05)[31]
Meditation, hypnosis, guided imageryPain, nausea and vomitingDecrease pain, nausea, and vomiting (P < 0.05)[32,33]
Biologically based therapies
Vitamins and dietary supplementsHepatotoxicity and febrile neutropeniaFor hepatotoxicity, small studies found milk thistle, omega-3 fatty acids, and black seed oil to decrease liver enzymes (P < 0.05). For febrile neutropenia, wheat germ extract, probiotics, and honey showed promise in small studies[34-38]

A recent systematic review aimed to assess evidence on the effectiveness of HC for a range of symptom clusters in pediatric patients. Patients with both acute and chronic disorders demonstrated that the presence of HC during medical procedures, induction of anesthesia in the preoperative room, and for chronic conditions might be a beneficial strategy to manage symptom clusters compared to those who received only standard care[39]. A clown is a comic performer who employs theatrical production often in a mime style and wears outlandish and brightly colored costume to entertain a given public. In a hospital setting, clowns are called “hospital clowns” and are usually part of “therapeutic clowning” programs. There are currently many hospital clowning programs operating in several countries, such as Australia, New Zealand, United States, United Kingdom, Canada, Israel, Hong Kong and Brazil. Overall, HC provide a CT for health care by using several techniques such as music, juggling, improvisation, magic, storytelling, and puppets. They help create a positive emotional state that promotes interaction between parents and the child and fosters a hopeful attitude[39].

A study of HCs recently evaluated its effect on the levels of CRF and stress in pediatric cancer patients receiving chemotherapy[26]. The results demonstrated that the total psychological stress and CRF levels improved after the HC compared to baseline (P = 0.003 and P = 0.04, respectively)[26]. A significant decrease in salivary cortisol after the HC visit was observed. In this study, the HC intervention was performed by volunteer clowns from the University of São Paulo, Brazil, and were members of the Laugh Company, which is an outreach project aimed to lift pediatric patient mood levels during hospitalization[26]. Their families and the staff were present during the clown visits and were delighted. Children accompanied by their parents interacted simultaneously with two volunteer clowns in the pediatric oncology ward for 30 minutes at a time. In this period, the clowns performed several activities while adapting their techniques to the best of their ability to each patient’s age and psychological condition. The 2 clowns arranged common play sessions with patients in their ward and used different methods for entertaining the children such as singing, dancing, magic tricks, gags, puppets, games, mostly using improvisation and their distinctive humor and charisma. All these HC attended specific training sessions focused on practical work situations to develop theatrical and artistic clown competences in addition to psychosocial and pedagogical skills (Table 2)[26].

Table 2 Protocol intervention hospital clowns as a complementary therapy for management psychological stress and cancer-related fatigue and enhancing the quality of life.
Item
Description
Ref.Lopes-Júnior et al[26]
ObjectiveTo assess the effect of a hospital clown intervention on the levels of stress and CRF in pediatric cancer patients receiving chemotherapy by measuring the levels of salivary cortisol and salivary alpha amylase
Sample16 children and adolescents (6-14 years old, mean ± SD: 11.40 ± 3.44) with cancer receiving a hospital clown intervention
Protocol of interventionThe participants served as their own controls before and post-intervention over a 3-day period. Each patient received 1 session of the HC and provided eight saliva samples (4 samples at pre-intervention and 4 samples at post-intervention). All saliva samples were collected each day at the same time for all patients to maintain comparability among participants and to avoid that differences would be a result of normal daily oscillations in biomarkers. Data were collected at + 1, + 4, + 9, and + 13 hours after awakening (8:30 am), i.e., at 9:30 am, 12:30 pm, 5:30 pm, and 9:30 pm, respectively. The 8 points chosen for saliva collection were based on international recommendations for children and adolescents, to allow a better characterization of the biomarker circadian rhythms. In order to minimize external influences of measurements, at all sample collection time points, pediatric cancer inpatients had no invasive procedures or any other acute stresses in the last hour before sample collection and underwent preparation for saliva collection - which consisted of not ingesting any food or drinks 1 hour before the procedure and not brushing the teeth or using mouthwash before collection. After preparation had been completed, participants were requested to refrain from swallowing briefly (for 30 seconds) and then “drooling” the saliva from the mouth directly into the collection device
Outcome measureCRF and psychological stress. Children: PedsQL MFS (CRF scale-cancer module) and ESI (stress scale). Parents: PedsQL MFS
Main resultsParticipants mean age was 11.4 ± 3.4 years old. 50% were white, and 68.7% had completed primary school. Regarding the neoplasms, 6 was osteosarcoma, 4 ALL and 4 lymphoma. Most (81.3%) were primary neoplasm, and among the 16 patients, 68.7% had metastases. Also, 56.3% were using corticosteroids during the chemotherapy protocol. In comparison with baseline measurements, the total stress and CRF levels improved at the post-hospital clown intervention (P = 0.003 and P = 0.04, respectively). Salivary cortisol showed a significant decrease after clown intervention at the collection time points + 1, + 9, and + 13 hours (P < 0.05), but not α-amylase. The total ESI stress scores from the pediatric patients correlated positively with AUC for cortisol at pre-intervention (r = 0.35, P = 0.03). Decreased stress scoring after the clown intervention correlated positively with decreased levels of cortisol (r = 0.02, P = 0.04). Contrary, the total ESI stress scores from the patients correlated negatively with AUC for α-amylase at pre-intervention (r = -0.57, P = 0.02), but not at the post-intervention. These findings suggest that the hospital clowns as a complementary therapy may improve stress and CRF
IMPLICATIONS FOR CLINICAL PRACTICE AND RESEARCH

Perhaps the addition of an HC to the play therapy portion of patient care could be a key addition to the oncology team and could be a valuable supplement to current play therapy practices. This could also be considered for outpatient treatment areas as well. HC have been a mainstay in a child’s life for decades[40-43] and may actually be an underused resource[13,26] for improving the oncology child’s daily regime while undergoing treatment in the any setting[39]. Nurses play a pivotal role in the identification, monitoring, and risk evaluation of CSCs, including the assessment of biomarkers[44,45]. The understanding of how neuro-immunoendocrine pathways regulate cancer development and the underlying aspects of treatment using biomarkers is urgent to incorporate into clinical practice.

One of the major challenges is to improve the preparation and training of nurses in omics sciences and disruptive technologies for the provision of personalized care, especially adapting curricula at different levels of academic training for these professionals, from undergraduate to postgraduate studies[46,47]. It is worth noting that for this century, one of the main challenges in nursing training is the integration of omics sciences into professional practice, which includes the analysis of biomarkers[47,48]. Therefore, there is an urgent need for extensive continuing education for nursing professionals, undergraduate/postgraduate course teachers and, mainly, the reformulation of more integrated nursing curricula, to adequately prepare the workforce for precision nursing in global health systems[46-48]. One of the main areas of application and development in precision nursing is oncology, where oncology nurses are already faced with the universe of omics sciences directly in the care of cancer patients, from prevention, diagnosis and oncological treatment through biomarkers, genetic tests, and pharmacogenomics, proteomics, metabolomics, genomics, and bioinformatics[49]. This understanding can contribute to elucidating the diagnosis and prognosis of several cancer types and assist in the selection of personalized CT for each patient and tumor type.

Another challenge is to ensure the transfer of these research results, so that they facilitate clinical decision-making towards personalized care[48]. In the last decade, the substantial growth of TR has opened up perspectives of knowledge in several directions, since they greatly assist in the elucidation of many pathophysiological processes associated with clinical practice and the singularities of patients[49]. Therefore, it is important that nursing is also involved in this type of research, since the application of the discoveries and results of TR carried out by these professionals supports evidence-based nursing[46,49].

CONCLUSION

It is crucial that nurses participate in identifying strategies to accelerate TR for assisting the understanding of the underlying pathophysiological mechanisms associated with CSC to intervene effectively. Overall, the literature suggests that CT may help improve pediatric cancer patient’s QoL as part of a comprehensive cancer care model. HCs may be a unique, useful intervention that could be integrated into patient’s care to decrease stress, CRF and improve QoL. Finally, oncology nurses using trained qualified CT therapists for various CT interventions can support the patient’s recovery from life-threatening illness.

ACKNOWLEDGEMENTS

We thank the Coordination of Improvement of Higher Education Personnel (CAPES), Brazil, for supporting this research with regular doctoral scholarship to Lopes-Júnior LC as well as a doctoral fellowship/internship at the University of Alberta, Edmonton, Canada. We also thank the National Council for Scientific and Technological Development (CNPq), Brazil, for a scholarship to Lopes-Júnior LC for Research Productivity PQ-Level 2A CNPq.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Medicine, research and experimental

Country of origin: Brazil

Peer-review report’s classification

Scientific Quality: Grade B, Grade B

Novelty: Grade B, Grade B

Creativity or Innovation: Grade B, Grade B

Scientific Significance: Grade B, Grade B

P-Reviewer: Nkomo T; Swarnakar R S-Editor: Wei YF L-Editor: A P-Editor: Zhao YQ

References
1.  GBD 2017 Childhood Cancer Collaborators. The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017. Lancet Oncol. 2019;20:1211-1225.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 143]  [Cited by in F6Publishing: 199]  [Article Influence: 33.2]  [Reference Citation Analysis (0)]
2.  Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12-49.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 1861]  [Article Influence: 1861.0]  [Reference Citation Analysis (2)]
3.  Rodgers C, Hooke MC, Ward J, Linder LA. Symptom Clusters in Children and Adolescents with Cancer. Semin Oncol Nurs. 2016;32:394-404.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 26]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
4.  Linder LA, Hooke MC. Symptoms in Children Receiving Treatment for Cancer-Part II: Pain, Sadness, and Symptom Clusters. J Pediatr Oncol Nurs. 2019;36:262-279.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 59]  [Article Influence: 11.8]  [Reference Citation Analysis (0)]
5.  National Center for Complementary and Integrative Health  Complementary, Alternative, or Integrative Health: What’s in a Name? [cited 15 March 2024]. Available from: https://www.nccih.nih.gov/health/complementary-alternative-or-integrative-health-whats-in-a-name.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Diorio C, Lam CG, Ladas EJ, Njuguna F, Afungchwi GM, Taromina K, Marjerrison S. Global Use of Traditional and Complementary Medicine in Childhood Cancer: A Systematic Review. J Glob Oncol. 2017;3:791-800.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 46]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
7.  Ringborg U. Translational cancer research - a coherent cancer research continuum. Mol Oncol. 2019;13:517-520.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 13]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
8.  Reid M, Yasko J. The role of biomarkers in cancer clinical trials. Semin Oncol Nurs. 2012;28:116-121.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 4]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
9.  Moore DC, Guinigundo AS. The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology. J Adv Pract Oncol. 2023;14:15-37.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 5]  [Reference Citation Analysis (0)]
10.  Dantzer R, Meagher MW, Cleeland CS. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol. 2012;9:414-426.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 103]  [Cited by in F6Publishing: 109]  [Article Influence: 8.4]  [Reference Citation Analysis (0)]
11.  Kim HJ, Barsevick AM, Fang CY, Miaskowski C. Common biological pathways underlying the psychoneurological symptom cluster in cancer patients. Cancer Nurs. 2012;35:E1-E20.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 99]  [Cited by in F6Publishing: 133]  [Article Influence: 11.1]  [Reference Citation Analysis (0)]
12.  Berger AM, Yennu S, Million R. Update on interventions focused on symptom clusters: what has been tried and what have we learned? Curr Opin Support Palliat Care. 2013;7:60-66.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 30]  [Cited by in F6Publishing: 30]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
13.  Lopes-Júnior LC, Pereira-da-Silva G, Silveira DSC, Veronez LC, Santos JC, Alonso JB, Lima RAG. The Effect of Clown Intervention on Self-Report and Biomarker Measures of Stress and Fatigue in Pediatric Osteosarcoma Inpatients: A Pilot Study. Integr Cancer Ther. 2018;17:928-940.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 26]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
14.  Tortora S, Raghunathan NJ, Seifert G, Sibinga EMS, Ghelman R. A comprehensive definition for pediatric integrative oncology through an international consensus. Complement Ther Med. 2021;57:102678.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
15.  Patel P, Robinson PD, van der Torre P, Tomlinson D, Seelisch J, Oberoi S, Morgan JE, Hinds PS, Götte M, Gibson F, Duong N, Davis H, Culos-Reed SN, Cataudella D, Miranda V, Dupuis LL, Sung L. Guideline for the management of fatigue in children and adolescents with cancer or pediatric hematopoietic cell transplant recipients: 2023 update. EClinicalMedicine. 2023;63:102147.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
16.  Ladas EJ. Integrative Medicine in Childhood Cancer. J Altern Complement Med. 2018;24:910-915.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
17.  Ladas EJ, Marjerrison S, Arora B, Hesseling PB, Ortiz R, Antillon F, Jatia S, Afungchwi GM. Traditional and Complementary Medicine in Pediatric Oncology and Low-Middle Income Countries: Recommendations from the International Society of Pediatric Oncology (SIOP), T&CM Collaborative. J Natl Cancer Inst Monogr. 2017;2017.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
18.  Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT. Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics. 2010;125:768-776.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 151]  [Cited by in F6Publishing: 148]  [Article Influence: 9.9]  [Reference Citation Analysis (0)]
19.  Ben-Arye E, Samuels N, Seifert G, Gressel O, Peleg R, Jong M. Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review. Curr Oncol Rep. 2024;26:714-734.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
20.  St Jude Children’s Research Hospital  Complementary Therapies and Integrative Health. [cited 15 March 2024]. Available from: https://together.stjude.org/en-us/treatment-tests-procedures/integrative-medicine.html.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Escalona A, Field T, Singer-Strunck R, Cullen C, Hartshorn K. Brief report: improvements in the behavior of children with autism following massage therapy. J Autism Dev Disord. 2001;31:513-516.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 93]  [Cited by in F6Publishing: 65]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
22.  Beider S, Moyer CA. Randomized controlled trials of pediatric massage: a review. Evid Based Complement Alternat Med. 2007;4:23-34.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 63]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
23.  Reindl TK, Geilen W, Hartmann R, Wiebelitz KR, Kan G, Wilhelm I, Lugauer S, Behrens C, Weiberlenn T, Hasan C, Gottschling S, Wild-Bergner T, Henze G, Driever PH. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology. Interim results of a multicenter crossover study. Support Care Cancer. 2006;14:172-176.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 54]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
24.  Cohen SO, Walco GA. Dance/Movement therapy for children and adolescents with cancer. Cancer Pract. 1999;7:34-42.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 34]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
25.  Aktas G, Ogce F. Dance as a therapy for cancer prevention. Asian Pac J Cancer Prev. 2005;6:408-411.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Lopes-Júnior LC, Silveira DSC, Olson K, Bomfim EO, Veronez LC, Santos JC, Alonso JB, Nascimento LC, Pereira-da-Silva G, Lima RAG. Clown Intervention on Psychological Stress and Fatigue in Pediatric Patients With Cancer Undergoing Chemotherapy. Cancer Nurs. 2020;43:290-299.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 20]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
27.  Kristensen HN, Laugesen B, Stinson J, Haslund-Thomsen H. The Impact and Influence of Hospital Clowns on Hospitalized Children Undergoing Painful Procedures: A Mixed Methods Study. Glob Qual Nurs Res. 2023;10:23333936231186599.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
28.  Arriaga P, Melo AS, Caires S. The Effects of Hospital Clowning on Physical and Emotional States of Pediatric Patients During Chemotherapy Treatment. Child Youth Care Forum. 2020;49:365-381.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 6]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
29.  Urbanski BL, Lazenby M. Distress among hospitalized pediatric cancer patients modified by pet-therapy intervention to improve quality of life. J Pediatr Oncol Nurs. 2012;29:272-282.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 34]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
30.  Silva NB, Osório FL. Impact of an animal-assisted therapy programme on physiological and psychosocial variables of paediatric oncology patients. PLoS One. 2018;13:e0194731.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 35]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
31.  Fukuhara JS, O'Haver J, Proudfoot JA, Spies JM, Kuo DJ. Yoga as a Complementary and Alternative Therapy in Children with Hematologic and Oncologic Disease. J Pediatr Oncol Nurs. 2020;37:278-283.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 4]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
32.  Ball TM, Shapiro DE, Monheim CJ, Weydert JA. A pilot study of the use of guided imagery for the treatment of recurrent abdominal pain in children. Clin Pediatr (Phila). 2003;42:527-532.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 53]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
33.  Zeltzer L, LeBaron S. Hypnosis and nonhypnotic techniques for reduction of pain and anxiety during painful procedures in children and adolescents with cancer. J Pediatr. 1982;101:1032-1035.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 239]  [Cited by in F6Publishing: 239]  [Article Influence: 5.6]  [Reference Citation Analysis (0)]
34.  Garami M, Schuler D, Babosa M, Borgulya G, Hauser P, Müller J, Paksy A, Szabó E, Hidvégi M, Fekete G. Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients. J Pediatr Hematol Oncol. 2004;26:631-635.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Ladas EJ, Kroll DJ, Oberlies NH, Cheng B, Ndao DH, Rheingold SR, Kelly KM. A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL). Cancer. 2010;116:506-513.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 54]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
36.  Wada M, Nagata S, Saito M, Shimizu T, Yamashiro Y, Matsuki T, Asahara T, Nomoto K. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer. 2010;18:751-759.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 91]  [Cited by in F6Publishing: 96]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
37.  Hagag AA, AbdElaal AM, Elfaragy MS, Hassan SM, Elzamarany EA. Therapeutic value of black seed oil in methotrexate hepatotoxicity in Egyptian children with acute lymphoblastic leukemia. Infect Disord Drug Targets. 2015;15:64-71.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 19]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
38.  Elbarbary NS, Ismail EA, Farahat RK, El-Hamamsy M. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study. Nutrition. 2016;32:41-47.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 32]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
39.  Lopes-Júnior LC, Bomfim E, Olson K, Neves ET, Silveira DSC, Nunes MDR, Nascimento LC, Pereira-da-Silva G, Lima RAG. Effectiveness of hospital clowns for symptom management in paediatrics: systematic review of randomised and non-randomised controlled trials. BMJ. 2020;371:m4290.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 37]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
40.  Vagnoli L, Caprilli S, Robiglio A, Messeri A. Clown doctors as a treatment for preoperative anxiety in children: a randomized, prospective study. Pediatrics. 2005;116:e563-e567.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 218]  [Cited by in F6Publishing: 192]  [Article Influence: 9.6]  [Reference Citation Analysis (0)]
41.  Kristensen HN, Sørensen EE, Stinson J, Thomsen HH. "WE do it together!" An Ethnographic Study of the Alliance Between Child and Hospital Clown During Venipunctures. J Pediatr Nurs. 2019;46:e77-e85.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 5]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
42.  Kocherov S, Hen Y, Jaworowski S, Ostrovsky I, Eidelman AI, Gozal Y, Chertin B. Medical clowns reduce pre-operative anxiety, post-operative pain and medical costs in children undergoing outpatient penile surgery: A randomised controlled trial. J Paediatr Child Health. 2016;52:877-881.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 30]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
43.  Dionigi A, Gremigni P. A combined intervention of art therapy and clown visits to reduce preoperative anxiety in children. J Clin Nurs. 2017;26:632-640.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 20]  [Cited by in F6Publishing: 22]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
44.  Miaskowski C, Aouizerat BE. Biomarkers: symptoms, survivorship, and quality of life. Semin Oncol Nurs. 2012;28:129-138.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 21]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
45.  Miaskowski C, Barsevick A, Berger A, Casagrande R, Grady PA, Jacobsen P, Kutner J, Patrick D, Zimmerman L, Xiao C, Matocha M, Marden S. Advancing Symptom Science Through Symptom Cluster Research: Expert Panel Proceedings and Recommendations. J Natl Cancer Inst. 2017;109.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 290]  [Cited by in F6Publishing: 290]  [Article Influence: 36.3]  [Reference Citation Analysis (0)]
46.  Tonkin E, Calzone KA, Badzek L, Benjamin C, Middleton A, Patch C, Kirk M. A Roadmap for Global Acceleration of Genomics Integration Across Nursing. J Nurs Scholarsh. 2020;52:329-338.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 20]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
47.  Calzone KA, Kirk M, Tonkin E, Badzek L, Benjamin C, Middleton A. Increasing nursing capacity in genomics: Overview of existing global genomics resources. Nurse Educ Today. 2018;69:53-59.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 25]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
48.  Dorsey SG, Pickler RH. Precision Science in Nursing Research. Nurs Res. 2019;68:85.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 3]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
49.  Yuan C. Precision Nursing: New Era of Cancer Care. Cancer Nurs. 2015;38:333-334.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 12]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]